Synchrony Financial Q2 2026 Earnings
EPS $2.59 (est $2.12) -Total Deposits $82.81B (Est $83.72B) -Cash & Cash Equivalents $16.19b (est $18.86b) -Net Interest Margin 15.1% (est 15.2%) -Net Interest Income $4.61b (est $4.68b) -Efficiency Ratio 35.8% (est 34.9%) -Provision For Credit Losses $1.20b (est $1.49b) -Sees Year EPS $9.25 To $9.50 (Saw ($9.10 To $9.50)
Story updates
10:05:08 AM UTC
SquawkNews
Adj EPS $1.94 (Est $1.84) -Adj. EBITDA $1.89b (Est $1.82b) -Sales $6.27b (Est $6.18) -Diagnostics Revenue $2.47b (Est $2.34b) -Life Sciences Rev. $1.88b (Est $1.8b) -Biotechnology Revenue $1.92b (Est $1.96b) -Adj. Oper Margin 27.1% (Est 26.6%) -Sees FY Adj EPS $8.45 To $8.60, Saw $8.35 To $8.55
10:10:19 AM UTC
SquawkNews
Synchrony Financial Q2 2026 Earnings
10:15:07 AM UTC
SquawkNews
Danaher Q2 2026 Earnings
EPS $2.59 (est $2.12) -Total Deposits $82.81B (Est $83.72B) -Cash & Cash Equivalents $16.19b (est $18.86b) -Net Interest Margin 15.1% (est 15.2%) -Net Interest Income $4.61b (est $4.68b) -Efficiency Ratio 35.8% (est 34.9%) -Provision For Credit Losses $1.20b (est $1.49b) -Sees Year EPS $9.25 To $9.50 (Saw ($9.10 To $9.50)